592
  • Executive interview - Race Oncology

    900 views 2 years ago
    Race Oncology is developing bisantrene, which had been the subject of over 40 clinical trials in the 1980s and 1990s as part of Lederle’s search for a safer anthracycline chemotherapy. Despite positive responses in a variety of cancers, especially AML (it was even approved for the treatment of AML in France, but never commercialised), development stopped after Lederle was sold to Wyeth and then Wyeth to Pfizer. Race will be developing bisantrene initially for relapsed/refractory AML and expects to start a pivotal trial for approval in the US around the end of 2018. Show less
    Read more
  • Uploads Play all

    • Nanoco Group - executive interview - Duration: 13 minutes, 13 seconds.

      • 6 days ago
      • 36 views
      In this video CEO Dr Michael Edelman begins by outlining the key developments in recent months. He explains why management decided to terminate the formal sale process and talks about the status of...
    • Media & Games Invest (MGI) - executive interview - Duration: 8 minutes, 15 seconds.

      • 6 days ago
      • 53 views
      Media and Games Invest's CEO, Remco Westermann, and CFO, Paul Echt, introduce MGI, a Xetra/Frankfurt-listed, free-to-play games and marketing business. Following the acquisition of the remaining mi...
    • Osirium Technologies - executive interview - Duration: 13 minutes, 35 seconds.

      • 1 week ago
      • 17 views
      UK-based Osirium Technologies designs and supplies subscription-based cybersecurity software, specialising in privileged access security. Its PAM platform supports privileged access, task, session ...
    • Blankstone Sington AIM IHT portfolio service: Edison's bull/bear game - Duration: 4 minutes, 29 seconds.

      • 1 week ago
      • 106 views
      In Edison’s bull/bear game, Stephen English, investment director and head of AIM at Blankstone Sington, takes a bearish stance on Fever-Tree Drinks, Andrew Bailey, Boohoo, virtual meetings and the ...
    • Pixium Vision - executive interview - Duration: 24 minutes.

      • 1 week ago
      • 121 views
      In this video, Rachel Carroll, president and managing partner of Edison Inc, interviews Lloyd Diamond, chief executive officer of Pixium Vision, about his first year with the company and the forthc...
    • OSE Immunotherapeutics - executive interview - Duration: 15 minutes.

      • 1 week ago
      • 156 views
      OSE Immunotherapeutics is an immunotherapy company based in Nantes and Paris, France, and is listed on the Euronext Paris exchange. It is developing immunotherapies for the treatment of solid tumou...
    • Acorn Income Fund – executive interview - Duration: 20 minutes.

      • 1 week ago
      • 85 views
      Acorn Income Fund smaller company co-managers Fraser Mackersie and Simon Moon (Unicorn) and income portfolio co-manager Chun Lee (Premier) give their thoughts on the COVID-19 pandemic, its impact o...
    • Genesis Emerging Markets Fund - executive interview - Duration: 12 minutes, 18 seconds.

      • 1 week ago
      • 64 views
      Genesis Emerging Markets Fund (GSS) was launched in July 1989 and was one of the first emerging markets funds to be listed in the UK. It aims to deliver long-term capital growth through investing i...
    • VolitionRx - executive interview - Duration: 8 minutes, 1 second.

      • 1 week ago
      • 24 views
      VolitionRx is a multinational epigenetics company developing simple, easy-to-use, cost-effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potentia...
    • Frenkel Topping - executive interview - Duration: 22 minutes.

      • 2 weeks ago
      • 55 views
      Richard Fraser, CEO of Frenkel Topping Group, a specialist asset manager and independent financial adviser focused on asset protection for vulnerable clients, describes the company’s key business e...
    • OnTheMarket - executive interview - Duration: 14 minutes, 34 seconds.

      • 2 weeks ago
      • 106 views
      In this interview, Clive Beattie, acting CEO of OnTheMarket, discusses how its eponymous property portal differs from the incumbent providers and how it has grown its market penetration. He then ta...
    • bet-at-home - executive interview - Duration: 7 minutes, 34 seconds.

      • 2 weeks ago
      • 54 views
      Michael Mubiru (Edison IR) interviews Franz Ömer (CEO of bet-at-home) following the company's Q120 results.

      They discuss the impacts of COVID-19 on gaming and sports betting, as well as updates on...
    This item has been hidden
  • This item has been hidden
to add this to Watch Later

Add to

Loading playlists...